|
|
Affymax Inc
OTC •
Healthcare •
Biotechnology •
Quote as of 06/16/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeOTC
Market Capitalization0.0412 mln
Float37.41 mln
Key Fundamentals
ROE112
RPS0.00
ROA-229
EBITDA, mln-47.65
EV / EBITDA0.07
Revenue, mln0.04
EV / Revenue-79.95
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
30% |
96
/ 100
 |
| 1 Month |
0% |
55
/ 100
 |
| 2 Months |
62.5% |
93
/ 100
 |
| 6 Months |
62.5% |
87
/ 100
 |
| 1 Year |
-69.77% |
8
/ 100
 |
|
| |
